End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.025 EUR | +0.83% | +4.31% | -34.24% |
Business Summary
Number of employees: 68
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thibaut du Fayet
CEO | Chief Executive Officer | 56 | 23-06-22 |
Eric Soyer
DFI | Director of Finance/CFO | 57 | 23-06-22 |
Pascal Birman
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-22 |
Cindy Fevre
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-22 |
Céline Breda
CTO | Chief Tech/Sci/R&D Officer | 54 | 23-06-22 |
Karine Charton
PRN | Corporate Officer/Principal | - | 23-06-22 |
General Counsel | - | 23-06-22 | |
Human Resources Officer | - | 23-06-22 | |
Jérôme Bailly
PRN | Corporate Officer/Principal | 45 | 23-06-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 23-06-22 | |
Hilde Windels
BRD | Director/Board Member | 59 | 23-06-22 |
Gil Beyen
BRD | Director/Board Member | 62 | 23-06-22 |
Martine George
BRD | Director/Board Member | 76 | 23-06-22 |
Director/Board Member | 66 | 23-06-22 | |
Didier Hoch
CHM | Chairman | 68 | 23-06-22 |
Leila Nicolas
BRD | Director/Board Member | - | 23-06-22 |
Robert Sebbag
BRD | Director/Board Member | 73 | 23-06-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,075,105 | 5,597,574 ( 92.14 %) | 250 ( 0.004115 %) | 92.14 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
250 | 0.00% | 791 $ |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.24% | 19.88M | |
+7.66% | 111B | |
+11.09% | 106B | |
-12.29% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.61% | 16.81B | |
+38.92% | 12.54B | |
-24.71% | 8.09B |
- Stock Market
- Equities
- PHXM Stock
- Company PHAXIAM Therapeutics S.A.